SCMR

Intramuscular Lipoma with Right Ventricular Outflow Tract Extension

Vatsal Patel1, Chirag Mehta MD1, Michael K. Atalay MD PhD2, Suhani Desai1, and Yash Patel MD MPH1
1Department of Cardiology, Brown University, Providence, RI, USA 
2Department of Radiology, Brown University, Providence, RI, USA

 

Clinical History

A 68-year-old female with no significant past medical history presented to her primary care office for an annual follow-up visit. Vitals and physical examination were unremarkable. Routine blood work revealed an low density lipoprotein level elevated to 140 mg/dL (normal range: 70-129 mg/dl), but the patient declined cholesterol lowering medication. In response, the primary team opted for coronary calcium scoring to help guide future discussions on cardiovascular risk factor reduction. Incidentally, her cardiac computed tomography (CT) demonstrated an incompletely evaluated 2 cm fat containing mass likely in the distal septum (Figure 1) with 97 Hounsfield unit (HU). These findings prompted cardiovascular magnetic resonance (CMR). 

Figure 1. Cardiac CT Axial Plane. Homogenous, low-attenuation mass (HU 97) in the interventricular septum, consistent with a lipoma.  

 

CMR Findings

CMR imaging was done on 1.5T Aera scanner (Siemens Healthineers, Erlangen Germany). CMR revealed a 2.5 x 1.8 cm mass in the distal interventricular septum with an attached 1.3 x 0.8 cm mobile nodular excrescence protruding into the right ventricular outflow tract (RVOT) (Movie 1, Figure 2). The mass was hyperintense to myocardium on T1 weighted (T1w) images with heterogeneous intensity on T2 weighted (T2w) image and bore a classic india ink appearance on balanced steady state free precession (bSSFP) cine images. There was no contrast uptake of the ventricular septal mass during perfusion (Movie 2). There was no obvious gadolinium uptake on late gadolinium enhancement (LGE) images (phase sensitive inversion recovery (PSIR) sequence). Right ventricular (RV) size was normal (right ventricular end-diastolic volume index 52 ml/m2) and function was normal (right ventricular ejection fraction 67%). Given the location and extension of the mass into the RVOT and the subsequent risk of RVOT obstruction and further embolization into the pulmonary artery, repeat CMR at few intervals were recommended. Two repeat CMRs, one at 9 months and another at 21 months, after the initial CMR showed stability in the size of the intramyocardial lipoma, measuring 2.5 x 1.7 cm and 2.4 x 1.8 cm respectively without further extension causing RVOT obstruction or embolization into the pulmonary circulation (Figure 3).

Movie 1. Axial (A,B) and mid short axis (C,D) cine bSSFP showing a mass in the distal interventricular septum with an attached mobile nodular excrescence protruding into the RVOT (arrows). 
Figure 2. Axial T1w (A) shows hyperintense mass (arrow) in the ventricular septum. T2w short tau inversion recovery (STIR) image (B) shows an isointense mass (arrow) in the ventricular septum. Axial cine bSSFP at end-diastole (C) shows a pedunculated mobile non-enhancing hyperintense mass within the interventricular septum that extends into the RVOT (green arrow). Mid short axis PSIR (D) image shows a hypointense mass in the ventricular septum.
Movie 2. Mid short axis perfusion with no contrast uptake of the mass in the ventricular septum and RVOT. 
Figure 3. Baseline axial cine bSSFP end-diastole (A) that demonstrates a hyperintense mass in the distal interventricular septum that has remained stable on 9-month follow up (B) and 21-month follow up (C). 

 

Conclusion

Taken together, the CMR features were highly suggestive of an intramyocardial lipoma. The patient is currently doing well without symptoms. Patient was asymptomatic from cardiovascular standpoint. She was reluctant to undergo invasive procedures, including a transvenous biopsy, and is instead being closely monitored in the outpatient setting. The diagnosis of intramyocardial lipoma was presumptive based on CMR findings. Intramyocardial lipomas are rare occurrences. Myocardial association is uncommon and involvement of the RVOT is rare. Patients are usually asymptomatic but may develop a variety of symptoms depending on mass location. Transthoracic echocardiography (TTE) plays an useful role in screening for cardiac lipomas, but cardiac CT and particularly CMR are indicated for accurate diagnosis. Transvenous biopsy should be pursued if imaging features are concerning for liposarcoma. Surgical resection is appropriate for symptomatic patients who are agreeable candidates, but management for asymptomatic remains controversial and should be individualized. 

 

Perspective

Primary cardiac tumors are a group of rare entities, with a frequency ranging between 0.17% and 0.19% based on population studies and autopsy series.[1] The most common primary cardiac tumors are myxomas, followed by papillary fibroelastomas, and lastly lipomas which account for approximately 2.4% to 8.4% of benign primary tumor cases.[2] Histologically, lipomas can be subdivided based on encapsulation status: (1) myocardial lipoma, (2) lipomatous hypertrophy of the interatrial septum, and (3) intramuscular lipoma, also known as lipomatous infiltration.[3] Myocardial lipomas are true neoplasms, reflecting an encapsulated mass of mature adipocytes and entrapped cardiomyocytes. Lipomatous hypertrophy of the interatrial septum represents an area of adipocyte hyperplasia and entrapment during embryogenesis that is focal to the interatrial septum, resulting in increased interatrial septum thickness usually exceeding 2 cm with sparing of the fossa ovalis with a resultant bilobed “dumbbell” appearance. Lipomatous infiltration refers to unencapsulated invasion of fatty tissue into the myocardium, often due to connective tissue metaplasia arising from the epicardium. On gross examination, lipomas manifest as polyploid or sessile masses and may arise from any of the three layers of cardiac tissue, with a predilection for the subendocardium of the right atrium as well as the visceral and parietal pericardium.[4] Myocardial involvement is less common, but when present, occurs more frequently in the left ventricle as opposed to the RV. Indeed, in one comprehensive literature review of cardiac lipomas from 1995-2014, 208 cases were identified and only 10 tumors were reported in the RV.[5] A case of a lipoma in the RVOT has been previously reported requiring surgery.[6]

Although most cardiac lipomas are asymptomatic and incidentally discovered, symptoms can still occur depending on mass size and location. Subendocardial lipomas with intracavitary extension may precipitate symptoms of heart failure due to valvular involvement or flow obstruction. Myocardial masses may present with palpitations, fatigue, exercise intolerance, dizziness, or sudden cardiac death due to various conduction system disturbances, fatal arrhythmia as the tumor can be a nidus for arrhythmogenesis, or impedance to myocardial contractility.[7] Giant subepicardial masses can cause compression of right sided chambers with resultant tamponade physiology. Anginal symptoms can occur with compression of the coronary arteries. Several atypical presentations such as unexplained fever, epistaxis, and hypertension have also been suggested. Thromboembolism is rare given that most lipomas are encapsulated.[8]

TTE remains the first-line screening modality for cardiac masses because of its availability, lack of radiation or contrast exposure, and real-time assessment for hemodynamic insults. However soft-tissue assessment is limited making it poorly suited to characterize tumors. Moreover, a global anatomic perspective of the mass in relation to nearby structures is not provided. In this regard, high resolution imaging with cardiac CT and particularly CMR prove valuable. On cardiac CT, the lipoma appears as a well-circumscribed homogeneous hypodense, fat attenuated mass (less than -50 to -150 HU). CMR is superior to cardiac CT in differentiating between lipomas and other primary cardiac tumors. CMR offers multiplanar imaging without reconstruction, and excellent soft-tissue contrast for tissue characterization. On CMR, the lipoma bears characteristic features of adipose tissue: hyperintense on T1w images and T2w images with complete suppression on fat-saturated sequences. Another diagnosis to be considered for a fat-containing mass is liposarcoma, which contains soft-tissue nodules and septations that usually enhance with contrast and that are intermixed with areas of fat signal with invasion into nearby structures. In suspected cases, transesophageal-guided transvenous biopsy should be pursued for tissue diagnosis. MDM2 gene amplification is also useful for ruling out atypical and malignant lipomatous masses.[9] In this case, the CMR findings did not raise concern for liposarcoma and were instead more suggestive of a benign lipoma.

Given their low prevalence, there are no prospective, randomized controlled trials to guide treatment for lipomas. Surgical lipomectomy is justified for symptomatic masses, since radical resection has a 95% curative rate and excellent postoperative prognosis.[10] Recurrence is rare but may occur with incomplete removal of the capsule and or pedicle, or if there is diffuse infiltration into the myocardium. Although conservative management can be considered and individualized for asymptomatic patients, the literature suggests most receive prophylactic resection due to the risk for overgrowth and infiltration into the myocardium, which portends unfavorable future outcomes.[11] In this case, resection was offered given the precarious position of the mass, but the patient declined surgical intervention and opted for serial imaging monitoring.

Click here to review the entire CMR on CloudCMR. 

 

References

  1. Wu S, Teng P, Zhou Y, Ni Y. A rare case report of giant epicardial lipoma compressing the right atrium with septal enhancement. J Cardiothorac Surg. 2015 Nov 5;10:150.
  2. Li D, Wang W, Zhu Z, Wang Y, Xu R, Liu K. Cardiac lipoma in the interventricular septum: a case report. J Cardiothorac Surg. 2015 May 9;10:69.
  3. Barbuto L, Ponsiglione A, Del Vecchio W, Altiero M, Rossi G, De Rosa D, Pisani A, Imbriaco M. Humongous right atrial lipoma: a correlative CT and MR case report. Quant Imaging Med Surg. 2015 Oct;5(5):774-7.
  4. Ismail I, Al-Khafaji K, Mutyala M, Aggarwal S, Cotter W, Hakim H, Khosla S, Arora R. Cardiac lipoma. J Community Hosp Intern Med Perspect. 2015 Oct 19;5(5):28449.
  5. Fang L, He L, Chen Y, Xie M, Wang J. Infiltrating Lipoma of the Right Ventricle Involving the Interventricular Septum and Tricuspid Valve: Report of a Rare Case and Literature Review. Medicine (Baltimore). 2016 Jan;95(3):e2561.
  6. Bayat F, Ahmadi ZH, Behzadnia N, Dorudinia A, Jahangirifard A. Asymptomatic Giant Lipoma of the Right Ventricular Outflow Tract: A Case Report. J Tehran Heart Cent. 2017 Jul;12(3):142-144.
  7. D’Souza J, Shah R, Abbass A, Burt JR, Goud A, Dahagam C. Invasive Cardiac Lipoma: a case report and review of literature. BMC Cardiovasc Disord. 2017 Jan 14;17(1):28.
  8. Wang H, Hu J, Sun X, Wang P, Du Z. An asymptomatic right atrial intramyocardial lipoma: a management dilemma. World J Surg Oncol. 2015 Feb 6;13:20.
  9. Weaver J, Goldblum JR, Turner S, Tubbs RR, Wang WL, Lazar AJ, Rubin BP. Detection of MDM2 gene amplification or protein expression distinguishes sclerosing mesenteritis and retroperitoneal fibrosis from inflammatory well-differentiated liposarcoma. Mod Pathol. 2009 Jan;22(1):66-70.
  10. Singh S, Singh M, Kovacs D, Benatar D, Khosla S, Singh H. A rare case of a intracardiac lipoma. Int J Surg Case Rep. 2015;9:105-8.
  11. Shu S, Wang J, Zheng C. From pathogenesis to treatment, a systemic review of cardiac lipoma. J Cardiothorac Surg. 2021 Jan 6;16(1):1.
Case prepared by:
Jason N. Johnson, MD MHS
Editor-in-Chief, Cases of SCMR
Le Bonheur Children’s Hospital, The University of Tennessee Health Science Center, St. Jude Children’s Research Hospital